Batch BeaconUK recalls and safety alerts

Medicines defect noticeMHRA

Products defect notice over a quality concern

Medicine quality concernLow riskClass 4

Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone tablets in error.

Check your product

Only products that match these details are covered. Have your pack in front of you.

16 identifiers listed for this notice.

  • Product 1 28

    Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
    • NG4001
    • NG4002
    • NG5001
    • NH4001
    • NH4002
    • NH5001
    ExpiryOn the carton, blister or label.
    • JUL/2027
    • AUG/2027
    • MAR/2028
    First distributedOn the product, its label or its packaging.
    • 04/07/2025
    • 30/07/2025
    • 07/07/2025
    • 31/07/2025

  • Product 2 20

    Batch code
    • 151061
    Expiry
    • APR/2028
    First distributed
    • 15 Aug 2025

What to do now

A quality problem has been identified with Products.

  1. Keep taking your medicine unless a healthcare professional tells you otherwise.
  2. Check the batch number and expiry date on your pack against the list on this page.
  3. If it matches, your pharmacist can swap it or arrange an alternative.
  4. Report suspected side effects to the MHRA Yellow Card scheme.

Why it matters. The MHRA classifies medicines recalls from Class 1 (most serious) to Class 4 (caution in use). The notice below sets out the details.

Symptoms and when to get help

Look out for

  • a side effect you have not had before
  • your condition not being controlled as well as usual

Get help urgently

  • signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
  • if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111

This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.

Replacements and prescriptions

The MHRA notice tells pharmacies and healthcare professionals what to do. Patients should keep taking their medicine and ask a pharmacist before stopping.

An affected pack bought over the counter can be returned to where you bought it.

From the official notice

Published by the Medicines and Healthcare products Regulatory Agency (EL(25)A/44). Quoted as issued.

Summary

Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone tablets in error.

The risk

DMRC reference number DMRC-36849945/DMRC-36701307 Marketing Authorisation Holder

Advice for healthcare professionals

Healthcare professionals are advised to use caution and consider extra safeguards for these batches in robotic or automated dispensing system or stocking systems and should carry out manual dispensing and stocking, as appropriate. Pharmacy providers should also consider local assessments, in line with this notification and inform Relonchem Ltd of any stock that cannot be used in an automated dispensing system.

Losartan potassium & Losartan potassium/hydrochlorothiazide tablets

The product quality of the Losartan Potassium 50mg and 100mg coated tablets and Losartan potassium/Hydrochlorothiazide 50mg/12.5mg and 100mg/25mg coated tablets are not impacted by this issue, therefore the affected batches are not being recalled.

RelonChem Ltd have advised that a further 132 units of Losartan potassium/Hydrochlorothiazide 50mg/12.5mg and 4780 units of Losartan potassium/Hydrochlorothiazide 100mg/25mg will be released to the market to meet customer orders and supply requests. Stock will be marketed until 30 Nov 2025 and all new batches marketed after this date will be packed with the new GTIN barcodes.

All remaining stock of Losartan Potassium 50mg and 100mg coated tablets will not be onward distributed and future batches of Losartan Potassium 50mg and 100mg coated tablets will be marketed with the new GTIN barcodes.

Risperidone 0.5mg Tablets (Almus livery)

The product quality of the Risperidone 0.5mg tablets in Almus livery is not impacted by this issue, therefore the affected batches are not being recalled.

RelonChem Ltd have confirmed that no further product will be distributed with the duplicated barcodes. All new batches produced by the manufacturing site and distributed, will be packed with new EAN barcodes.

No action is needed from patients, continue to take medication from these batches as prescribed by your healthcare professional. The product quality and safety of the tablets are not affected by this issue. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.

Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Advice for patients

No action is needed from patients, continue to take medication from these batches as prescribed by your healthcare professional. The product quality and safety of the tablets are not affected by this issue. Patients should continue to take medicines from these batches as prescribed by your healthcare professional.

Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Open the MHRA notice

Questions

Why has Products been recalled?

A quality problem has been identified with Products. The MHRA classifies medicines recalls from Class 1 (most serious) to Class 4 (caution in use). The notice below sets out the details.

How do I know if my medicine is affected?

Compare the batch code, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.

What should I do now?

Keep taking your medicine unless a healthcare professional tells you otherwise. Check the batch number and expiry date on your pack against the list on this page.

Do I need a new prescription?

The MHRA notice tells pharmacies and healthcare professionals what to do. Patients should keep taking their medicine and ask a pharmacist before stopping. An affected pack bought over the counter can be returned to where you bought it.

Related notices